|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,887.00 JPY | -0.14% |
|
-4.89% | -10.60% |
| 07/05 | UK's MHRA approves Dawnzera for treatment of familial chylomicronemia syndrome | RE |
| 01/05 | Otsuka's Profit Jumps 15% in Q1 | MT |
| Capitalization | 1,09600Cr 693.21Cr 593.88Cr 543.01Cr 514.21Cr 952.01Cr 66TCr 959.69Cr 6.48TCr 2.52TCr 31TCr 2.6TCr 2.55TCr | P/E ratio 2026 * |
17.3x | P/E ratio 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise value | 83TCr 523.06Cr 448.11Cr 409.73Cr 388Cr 718.33Cr 50TCr 724.13Cr 4.89TCr 1.9TCr 24TCr 1.96TCr 1.92TCr | EV / Sales 2026 * |
0.63x | EV / Sales 2027 * | 0.59x |
| Free-Float |
59.17% | Yield 2026 * |
3.27% | Yield 2027 * | 3.47% |
| 1 day | -0.05% | ||
| 1 week | -4.89% | ||
| Current month | -0.31% | ||
| 1 month | -4.04% | ||
| 3 months | -4.54% | ||
| 6 months | -4.23% | ||
| Current year | -10.60% |
| 1 week | 2,855.5 |  | 3,052 |
| 1 month | 2,827.5 | | 3,158 |
| Current year | 2,827.5 | | 3,308 |
| 1 year | 2,815 | | 3,353 |
| 3 years | 2,565 | | 3,789 |
| 5 years | 1,845 | | 3,789 |
| 10 years | 1,031.25 | | 3,789 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
PSD | President | 72 | 01/08/2001 |
Koichi Hisano
CMP | Compliance Officer | - | - |
Minoru Sakurai
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/03/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
BRD | Director/Board Member | 72 | 01/03/1992 |
| Director/Board Member | 73 | 01/03/1997 | |
| Director/Board Member | 75 | 01/03/2002 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +12.85% | 0.2% | 77 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | -4.89% | -1.15% | +10.92% | 709.95Cr | |
| -2.87% | -10.22% | -47.94% | -27.05% | 2.12TCr | |
| +0.15% | -7.46% | -18.16% | +18.03% | 1.56TCr | |
| +2.01% | +3.57% | +39.62% | +56.73% | 930.27Cr | |
| -2.98% | -5.98% | -12.59% | +72.36% | 413Cr | |
| 0.00% | -5.73% | -38.32% | -9.76% | 399.19Cr | |
| -5.58% | -2.25% | +115.54% | +243.58% | 393.65Cr | |
| +6.26% | +2.15% | +53.00% | +204.18% | 341.66Cr | |
| -4.01% | -6.11% | -8.89% | -32.31% | 208.26Cr | |
| -2.33% | -3.26% | +8.50% | +19.91% | 197.74Cr | |
| Average | -0.92% | -2.88% | +8.96% | +55.66% | 726.92Cr | |
| Weighted average by Cap. | -0.90% | -4.42% | -6.99% | +30.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,30900Cr 828.03Cr 709.37Cr 648.61Cr 614.21Cr 1.14TCr 79TCr 1.15TCr 7.74TCr 3.01TCr 38TCr 3.11TCr 3.04TCr | 1,37200Cr 867.75Cr 743.4Cr 679.72Cr 643.68Cr 1.19TCr 83TCr 1.2TCr 8.11TCr 3.15TCr 39TCr 3.26TCr 3.19TCr |
| Net income | 6.33TCr 40Cr 34Cr 31Cr 30Cr 55Cr 3.83TCr 55Cr 374.24Cr 145.37Cr 1.82TCr 150.24Cr 147.03Cr | 6.83TCr 43Cr 37Cr 34Cr 32Cr 59Cr 4.13TCr 60Cr 403.61Cr 156.77Cr 1.96TCr 162.03Cr 158.57Cr |
| Net Debt | -27TCr -170.15Cr -145.77Cr -133.28Cr -126.22Cr -233.67Cr -16TCr -235.56Cr -1.59TCr -617.84Cr -7.73TCr -638.55Cr -624.92Cr | -29TCr -182.88Cr -156.67Cr -143.25Cr -135.66Cr -251.15Cr -17TCr -253.18Cr -1.71TCr -664.06Cr -8.31TCr -686.31Cr -671.66Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 2,887.00 ¥ | -0.14% | 2,57,700 |
| 14/26/14 | 2,891.00 ¥ | -2.18% | 18,30,100 |
| 13/26/13 | 2,955.50 ¥ | +0.70% | 15,00,300 |
| 12/26/12 | 2,935.00 ¥ | -3.61% | 18,19,600 |
| 11/26/11 | 3,045.00 ¥ | +0.23% | 16,52,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4768 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition